Design, Synthesis, In Vitro Hydrolysis and Biological Evaluation of Antioxidant-Conjugated Mutual Prodrugs of Naproxen Rajat Goyal, Sumeet Gupta, Prabodh Chander Sharma, Hitesh Chopra Russian Journal of Bioorganic Chemistry, 2026 Objective: A novel series of antioxidant-conjugated mutual prodrugs of naproxen (RJ-01-01–RJ-01-10) was designed and synthesized to mitigate the gastrointestinal (GI) adverse effects associated with the parent drug, naproxen. Methods: The study included molecular docking, synthesis and characterization, in vitro hydrolysis, and biological evaluation. Results and Discussion: The synthesized prodrugs demonstrated high stability in simulated gastric fluid (SGF, pH 1.2), with minimal hydrolysis to the parent naproxen (18.62–24.14%), indicating reduced potential for gastric irritation. Conversely, in simulated intestinal fluid (SIF, pH 7.4), a significantly higher hydrolysis rate (75.07–84.01%) was observed, facilitating drug release and intestinal absorption. In docking studies, compounds RJ-01-04, RJ-01-05, RJ-01-06, RJ-01-08, and RJ-01-09 exhibited the highest binding energies (–13.68, –12.23, –13.74, –12.01, and –13.06 kcal/mol, respectively) compared to naproxen. During in vitro evaluation, RJ-01-04 showed significantly more potent COX-2 inhibition (IC50 = 44.18 ± 1.7 µM) than naproxen (IC50 = 61.48 ± 0.8 µM) and comparable COX-1 inhibition (IC50 = 55.34 ± 0.6 vs. 59.43 ± 0.5 µM for naproxen), indicating dual inhibitory activity. In AGS cells, RJ-01-04 reduced reactive oxygen species (ROS) levels and increased superoxide dismutase (SOD) activity more effectively than naproxen, demonstrating enhanced antioxidant effects. Western blot analysis confirmed downregulation of COX-2 and COX-1 protein expression in AGS cells treated with RJ-01-04. Cytotoxicity assessment (MTT assay) in HEK293 cells revealed that RJ-01-04 exhibited significantly lower cytotoxicity than naproxen. Conclusions: These findings support the mutual prodrug strategy as a promising approach to improve the therapeutic profile of naproxen through antioxidant conjugation.
Pathophysiology and Molecular Basis of Psoriasis Kashish Wilson, Tanvi, Rajat Goyal, Sumeet Gupta, Chander Parkash Dora, Garima Novel Carriers for Psoriasis Management and Pharmacotherapy, 2026 Psoriasis, a papulosquamous skin disease, is estimated to affect 2% of the global population. Traditionally believed to be a problem largely affecting keratinocytes in the epidermis, psoriasis has recently been identified as one of the most common immune-related diseases. Though this condition may manifest at any life stage, a dual distribution of age was observed, having a peak occurring between the ages of 20 and 30 as well as 50 and 60. Psoriasis possesses a complicated etiology that includes immunologic, hereditary, and systemic/local factors. Psoriasis shows an immense negative impact on human life quality, probably equivalent in comparison to coronary artery disease, type 2 diabetes, depressive disorders, and carcinoma, regardless of the fact that it usually possesses a minor influence on survival. The unregulated development of keratinocytes is the main constraint behind psoriasis, and improper regulation of the immune system serves as a pathophysiological factor. The pathogenesis generally includes the cooperation among several populations for immunocytes along with corresponding transmitting molecules that are: (1) innate immunocytes, which are mediated by antigenic-displaying cells, such as neutrophils, the cells of Langerhans, and natural-killing T lymphoid cells (2) acquired or adaptable immunocytes, which are facilitated by developed CD4+ and CD8+ T lymphocyte residing in the epidermis. The result of such immunological dysfunction leads to inflammation, which causes clinical lesions as well as histopathological inflammation, diagnostic of psoriasis development and perpetuation. The standard of lifestyle in patients has increased with biologic treatments, which focus on the cytokine-mediated pathophysiology of psoriasis. This book chapter will cover the molecular basis and primary pathophysiology of psoriasis.
Harnessing Nanoemulsions for Tailored Breast Cancer Therapy: Recent Insights and Opportunities Sneep Kumar Chaturvedi, Gulshan Sharma, Sanskriti Saini, Sushma Jain, Karan Wadhwa, Rajat Goyal, Hardeep Singh Tuli, Rakesh Pahwa Current Drug Research Reviews, 2026 Breast cancer is classified as the most prominent and aggressive form of cancer, predominantly affecting women worldwide, underscoring an imperative need for the development of innovative treatment strategies. Despite the vast array of treatment methods, including surgical removal, hormone therapy, gene therapy, radiation therapy, etc., these methods are primarily associated with significant drawbacks, such as a lack of site-specificity and multidrug resistance. In the pursuit of more effective breast cancer treatments, nanoemulsions emerge as an exceptionally promising alternative. Nanoemulsions represent an advanced drug delivery platform for a wide range of therapeutics, including chemotherapeutic agents, essential oils, herbal actives, and genetic material, offering innovative strategies for breast cancer management. Nanoemulsions offer distinct therapeutic advantages by enhancing solubility and bioavailability, increasing drug-loading efficiency, and enabling controlled, site-specific release of anticancer agents. They promote apoptosis, modulate multidrug resistance, and reduce systemic toxicity, thereby improving overall therapeutic efficacy. Furthermore, surface-functionalized nanoemulsions with targeting ligands markedly improve tumor selectivity, while localized delivery strategies, such as intraductal administration, prolong drug retention and minimize offtarget effects. This paper presents a comprehensive overview of breast cancer development and progression, emphasizing the therapeutic relevance of nanoemulsions. Although treating breast cancer with nanoemulsions holds extensive therapeutic promise, there remains considerable scope to reveal novel findings that can enhance their clinical applicability, thus offering promising avenues for further advancements.
Unlocking the Therapeutic Potential of Piperine - From Ethnopharmacology to Nanodelivery Strategies Karan Wadhwa, Jasmine Sagwal, Rohil Panwar, Dolly Koli, Rakesh Pahwa, Rajat Goyal, Poonam Negi, Ravinder Verma Current Nanomedicine, 2026 Herbs have long been esteemed for their therapeutic properties and utilized to treat a broad spectrum of diseases. Notably, piperine is a naturally occurring alkaloid abundantly found in numerous plants, with four isomeric variants. Contemporary literature has revealed that piperine has significant pharmacological activities, including cardioprotective, neuroprotective, gastroprotective, hepatoprotective, nephroprotective, anti-allergic, anti-cancer, antiinflammatory, anti-diabetic, anti-microbial, and many more. Piperine's diverse pharmacological profile not only reveals its versatility in experimental studies but also highlights its effectiveness in numerous clinical outcomes. However, despite the therapeutic benefits evident from numerous animal and human investigations, the clinical relevance of piperine faces numerous challenges because of its low aqueous solubility, stability, and limited bioavailability. To address these constraints, nanoformulations like nanoparticles, liposomes, micelles, gold nanogels, nanosuspensions, nanoemulsions, and self-nanoemulsifying drug delivery systems have emerged as innovative approaches that play a crucial role in optimizing the bioavailability and efficacy of piperine. By utilizing these novel drug delivery systems, piperine’s therapeutic potential can be harnessed, paving the way for its application in diverse clinical conditions. This manuscript seeks to advance the current understanding of piperine's therapeutic potential, elucidating its mechanistic insights against numerous disorders and exploring various nanoformulation strategies to optimize its delivery and efficacy.
Neuro-protective Potential of Honey: A Narrative Review Sumel Ashique, Anas Islam, Prashant Kumar, Samy Selim, Soad K. Al Jaouni, Ananya Chakraborty, Ivan Kahwa, Rajat Goyal, Shivani Chopra, Hitesh Chopra Current Pharmaceutical Design, 2026 Apitherapy, the therapeutic use of bee products, has attracted attention for its potential in treating various ailments. Honey is unique among bee products because it has a high concentration of medicinal chemicals. In recent years, there has been growing concern about exploring the neuroprotective features of honey. Our article aimed to consolidate existing research on the neuroprotective potential of honey, shedding more focus on its mechanisms of action and therapeutic properties. The literature suggests that honey exhibits neuroprotective properties by attenuating oxidative stress, alleviating neuroinflammation, and enhancing neuronal survival and regeneration. Especially, honey’s potential to mitigate neurodegenerative disorders and enhance cognitive function and memory. These reports position honey as a promising candidate for neuroprotection, offering a natural and accessible therapeutic option to combat neurological disorders. Its multifaceted mechanism of action makes it a valuable asset in neurotherapy. However, more research is warranted to clarify the specific compounds responsible for their neuroprotective effects and to optimize their therapeutic application. Unlocking the full potential of honey in neuroprotection could open the door to novel therapeutic approaches for the management of neurological conditions.
A Perspective Review on Animal Coronaviruses: From Infection Insights to Preventive Measures and Antiviral Advancements Tanvi, Rajat Goyal, Rupesh K. Gautam, Kashish Wilson, Kajal Garg, Tanmay Sharma, Sumeet Gupta, Sachin Kumar Singh, Haider Ali, Gaurav Gupta, Md Sadique Hussain Coronaviruses, 2026 Animal coronaviruses (CoVs) have emerged as significant pathogens with considerable implications for both animal and human health. This review provides an in-depth analysis of the origins, transmission dynamics, and pathogenic mechanisms of animal CoVs. We examine the viral entry, replication processes, and immune evasion strategies that enable CoVs to infect a variety of host species. Additionally, the review highlights recent advancements in prevention and therapeutic strategies, including the development of species-specific vaccines, enhanced biosecurity measures, and surveillance systems aimed at controlling zoonotic spillover. Furthermore, we discuss the latest antiviral strategies, including repurposed drugs, targeted molecular therapies, and the development of novel antiviral agents. This review emphasizes the importance of interdisciplinary research in advancing our understanding of animal CoVs and in developing effective interventions to mitigate their impact on global health.
Insights on Natural Products and Their Derivatives in Tuberculosis Management Rajat Goyal, Kumar Susheel, Kajal Garg, Rani Neha, Hitesh Chopra, Kashish Wilson, Sumeet Gupta Scripta Medica Banja Luka, 2025 Tuberculosis (TB), a bacterial disease primarily affecting middleas well as low-income countries, poses a significant public health threat. Natural products have historically been and remain a vital source of fresh medications for treating various diseases. The renewed interest in natural product research is partly a result of the increasing prevalence of drug-resistant Mycobacterium tuberculosis (MTb) strains along with adverse outcomes associated with firstand second-line anti-tubercular drugs. The TB complexity and the complications arising from the use of allopathic medications, such as multidrug resistance, highlight the effectiveness of natural medications in this context. Therefore, it is crucial to explore new treatment therapies to effectively mitigate the harmful effects associated with TB. More research is needed on various natural substances, both independently and in combination with currently approved drug regimens, as potential TB treatment options.
Insights on prospects of natural products in the management of autism Rajat Goyal, Namish Manchanda, Rupesh K. Gautam Empowering Innovations in Advanced Autism Research and Management, 2025 Autism spectrum disorder (ASD) is a multifaceted neurological condition that impedes an individual's capacity for communication and socialization for the rest life. Recurrent, capped behaviours which compromise cognitive function are indeed its hallmark. To treat behavioural issues linked to autism, speech therapy, occupational therapy, and special education programs have all been employed. The researchers also looked at using herbal remedies to treat autistic people because of the negative effects of ASD medications. Natural products have proven to be a viable treatment for a number of illnesses, including autism and other neurological problems. These naturally existing chemicals that are known to be likely candidates for psychotherapy may be employed as chemical models or templates for building novel materials that could be a remedy for autism. In this study, we discuss the physiological and epidemiological features of autism and the role of natural products in the treatment of autism.
Advancements and Applications of Herbal Cocrystals Rajat Goyal, Pankaj Popli, Kashish Wilson, Hitesh Chopra, Sonia Dhiman, Sumeet Gupta Cocrystals in Pharmaceutical Sciences Design to Applications, 2025
Nanomaterial-Based Vaccine Adjuvants Tanvi, Philips Kumar, Rajat Goyal, Kashish Wilson, Hitesh Chopra, Rajeev K. Singla Emerging Pathways of Vaccine Adjuvants A Nonspecific Stimulant of the Immune System, 2025
Decoding and Unravelling Mpox, Herpes, and Syphilis Infections: A State of Art Review Jiao Wang, Rajat Goyal, Rupesh K. Gautam, Kajal Garg, Shaheen Husain, Hitesh Chopra, Ankit Kumar Dubey, Rehab A. Rayan, Mohammad Amjad Kamal, Dinesh Kumar Mishra, Rohit Gundamaraju, Bairong Shen, Rajeev K. Singla Current Pharmaceutical Biotechnology, 2025
Health-promoting and medicinal properties of Zingiberaceae family plants: A minireview with a special focus on galangal, turmeric, cardamom, and ginger Maima Matin, Rajeev K. Singla, Artur Jóźwik, Jarosław Olav Horbańczuk, Natalia Ksepka, Kamil Wysocki, Thadiyan Parambil Ijinu, Neenthamadathil Mohandas Krishnakumar, Sreejith Pongillyathundiyil Sasidharan, Ifeoma C. Ezenyi, John Igoli, Fabio Fusi, Sara Frazzini, Luciana Rossi, Michel-Edwar Mickael, Abhishek Joshi, Olga Adamska, Artur Stolarczyk, Esra Capanoglu, Deniz Gunal-Koroglu, Shi-Hui Cheng, Omar M. Atrooz, Kiran Kharat, Ibrahim M. Abu-Reidah, Neeraj Rani, Atul Kabra, Ruchika Kabra, Dama Sreedhar Preethidan, Prathyusha Surendran, Emad Mohamed Abdallah, Seetha Harilal, Rajesh Kumar, Syed Abidullah, Hemanth Kumar Boyina, Vimal Arora, Prasanna Srinivasan Ramalingam, Sujatha Elangovan, Sivakumar Arumugam, Tanveer Alam, Edlira Aruci, Elena González-Burgos, Isabel Ureña-Vacas, Visitación López-Miranda, Esperanza Herradón, Rupesh Kumar Gautam, Rajat Goyal, Shah Alam Khan, Logesh Rajan, Joel Ojogbane Onoja, Sharad Vats, Akinleye Akinrinde, Smith B. Babiaka, Conrad V. Simoben, Doris E. Enow, Kennedy O. Abuga, Priti Talwar, Palaniyandi Ravanan, Reda El Boukhari, Ahmed Fatimi, Fabien Schultz, Ren-You Gan, Jean Noël Nyemb, Gaetan Bayiha Ba Njock, Constant Anatole Pieme, Goh Bey Hing, Ricardo Lagoa, Nikolay T. Tzvetkov, Farhan Bin Matin, Antonello Santini, Jaya Arora, Aswathy Chankaramkandath Vasu, Suraj Kadunganattil, Abeer Essam Noman, Luay M Alsubhi, Indra Lasmana Tarigan, Shafaat Yar Khan, Ali Zarrabi, Hefa Mangzira Kemung, Kavitha Raj Varadaraju, Tomasz M. Karpiński, Md. Mohaiminul Islam, Shaikh Jamal Uddin, Carmela Fimognari, Hari Prasad Devkota, Ivana Carev, Dongdong Wang, Kenneth Anchang Yongabi, Luther Bob Mbeku, Sohini Chakraborty, Sourav S. Patnaik, Shanmugam Thangapandiyan, Bikash Baral, Siva Sai Chandragiri, Eliana B. Souto, Gérard Lizard, Fatiha Brahmi, Farid Khallouki, Adil El Midaoui, Ronan Lordan, Anupam Bishayee, Meng-Yao Li, Monika Szymańska-Czerwińska, Krzysztof Niemczuk, Manik Chandra Shill, Michał Ławiński, Oleh Lushchak, Iwona Wojtasik-Kalinowska, Agnieszka Wierzbicka, Thomas Jakschitz, Mathew Dan, Imen Ghzaiel, Leila Rezig, Anne Vejux, Amira Zarrouk, Ahmad Ali, Andy Wai Kan Yeung, Günther K. Bonn, Bairong Shen, Atanas G. Atanasov Current Research in Biotechnology, 2025
Natural products in the management of neurodegenerative diseases Rajat Goyal, Pooja Mittal, Rupesh K. Gautam, Mohammad Amjad Kamal, Asma Perveen, Vandana Garg, Athanasios Alexiou, Muhammad Saboor, Shafiul Haque, Aisha Farhana, Marios Papadakis, Ghulam Md Ashraf Nutrition and Metabolism, 2024
Biomedical Applications of Alginates Payal Kesharwani, Swapnil Sharma, Vishal Chaudhary, Rajat Goyal, Rupesh K. Gautam Biopolymers for Biomedical Applications, 2024
A retrospective study on the impact of high-fat diets on human health related to metabolic associated diseases Everything You Need to Know about High Fat Diets, 2023
Biobased materials in nutraceuticals Rajat Goyal, Shruti Aggarwal, Vipin Saini, Rupesh K. Gautam, Shakeel Ahmed Advanced Applications of Biobased Materials Food Biomedical and Environmental Applications, 2023
Synbiotics in Colon Cancer Hitesh Chopra, Rajat Goyal, Atif Amin Baig, Sonia Arora, Kamal Dua, Rupesh K. Gautam Synbiotics for the Management of Cancer, 2023
Chemopreventive Potential of Dietary Nanonutraceuticals for Prostate Cancer: An Extensive Review Hitesh Chopra, Shabana Bibi, Rajat Goyal, Rupesh K. Gautam, Rashmi Trivedi, Tarun Kumar Upadhyay, Mohd Hasan Mujahid, Mohammad Ajmal Shah, Muhammad Haris, Kartik Bhairu Khot, Gopika Gopan, Inderbir Singh, Jin Kyu Kim, Jobin Jose, Mohamed M. Abdel-Daim, Fahad A. Alhumaydhi, Talha Bin Emran, Bonglee Kim Frontiers in Oncology, 2022
Design, synthesis, in-vitro hydrolysis and biological evaluation of antioxidant conjugated mutual prodrugs of ibuprofen R Goyal, PC Sharma, S Gupta Inflammopharmacology, 1-21 , 2026 2026
Design, Synthesis, In Vitro Hydrolysis and Biological Evaluation of Antioxidant-Conjugated Mutual Prodrugs of Naproxen R Goyal, S Gupta, PC Sharma, H Chopra Russian Journal of Bioorganic Chemistry 52 (1), 26 , 2026 2026 Citations: 1
Pathophysiology and Molecular Basis of Psoriasis K Wilson, R Goyal, S Gupta, CP Dora Novel Carriers for Psoriasis Management and Pharmacotherapy, 13-28 , 2026 2026
Exploring the pharmacokinetics, drug-likeness, and toxicological features of anticancer flavonoids: a Boulevard to explore their clinical translational potential AK Dubey, SS Chandragiri, AV Geevarghese, B Kapoor, M Gulati, P Rani, ... Frontiers in Pharmacology 16, 1648395 , 2025 2025 Citations: 8
Re-evaluating the Relationship between Cosmetic Products and Cancer: An Investigative Review of Paradigms P Kumar, PK Chakroborty, K Wilson, R Goyal, S Gupta, A Saharan, ... Current Cancer Therapy Reviews 21 (6), 757-770 , 2025 2025
Neuro-protective Potential of Honey: A Narrative Review S Ashique, A Islam, P Kumar, S Selim, SK Al Jaouni, A Chakraborty, ... Bentham Science Publishers , 2025 2025 Citations: 2
New insights on pharmacological potential of montelukast: a comprehensive review K Goel, D Singh, R Goyal, S Bansal, S Singh, N Sharma, S Gupta Inflammopharmacology 33 (8), 4205-4235 , 2025 2025 Citations: 4
Decoding and unravelling mpox, herpes, and syphilis infections: A state of art review J Wang, R Goyal, RK Gautam, K Garg, S Husain, H Chopra, AK Dubey, ... Current Pharmaceutical Biotechnology 26 (10), 1532-1548 , 2025 2025 Citations: 5
Neural Networks of Knowledge: Ontologies Pioneering Precision Medicine in Neurodegenerative Diseases P Mittal, RK Gautam, H Sharma, R Goyal, Garima 4, R Kapoor, D Kumar, ... Current Neuropharmacology , 2025 2025 Citations: 2
Nanomaterial‐Based Vaccine Adjuvants Tanvi, P Kumar, R Goyal, K Wilson, H Chopra, RK Singla Emerging Pathways of Vaccine Adjuvants: A Nonspecific Stimulant of the … , 2025 2025
Advancements and Applications of Herbal Cocrystals R Goyal, P Popli, K Wilson, H Chopra, S Dhiman, S Gupta Cocrystals in Pharmaceutical Sciences: Design to Applications, 153-187 , 2025 2025
Nano Selenium: A Promising Solution for Infectious Diseases-Current Status and Future Prospects S Husain, RMS Sultan, K Saxena, F Bano, R Goyal, S Chopra, H Chopra, ... Current Pharmaceutical Design , 2025 2025 Citations: 7
Phytochemical, Ethnobotanical, and Global Perspectives of Genus Echinacea : A Panoramic Review D Arora, S Parashar, RK Gautam, R Goyal Current Traditional Medicine 11 (2), E111023222049 , 2025 2025 Citations: 2
Green Synthesis of Copper Oxide Nanoparticles by Hydroethanolic Extract of Rubus ellipticus : Antimicrobial and Antidiabetic Activities A Kumari, L Kashyap, V Prakash, RK Gautam, R Goyal, V Chauhan Current Nanomedicine , 2025 2025
Harnessing Nanoemulsions for Tailored Breast Cancer Therapy: Recent Insights and Opportunities SK Chaturvedi, G Sharma, S Saini, S Jain, K Wadhwa, R Goyal, HS Tuli, ... Current Drug Research Reviews , 2025 2025
Unlocking the Therapeutic Potential of Piperine-From Ethnopharmacology to Nanodelivery Strategies K Wadhwa, J Sagwal, R Panwar, D Koli, R Pahwa, R Goyal, P Negi, ... Current Nanomedicine , 2025 2025 Citations: 1
Health-promoting and medicinal properties of Zingiberaceae family plants: A minireview with a special focus on galangal, turmeric, cardamom, and ginger M Matin, RK Singla, A Jóźwik, JO Horbańczuk, N Ksepka, K Wysocki, ... Current research in biotechnology 10, 100329 , 2025 2025 Citations: 4
Insights on natural products and their derivatives in tuberculosis management R Goyal, K Susheel, K Garg, R Neha, H Chopra, K Wilson, S Gupta Scripta Medica 56 (2), 315-328 , 2025 2025
Overview of monkeypox virus K Wilson, R Goyal, H Chopra, S Chopra, M Dhanawat Scripta Medica 56 (1), 185-197 , 2025 2025
Insights of Perspectives of Autism Spectrum Disorder S Sirswal, R Goyal, K Goel, RK Gautam, S Gupta Empowering Innovations in Advanced Autism Research and Management, 1-40 , 2025 2025
MOST CITED SCHOLAR PUBLICATIONS
Hydrazone comprising compounds as promising anti-infective agents: Chemistry and structure-property relationship PC Sharma, D Sharma, A Sharma, N Saini, R Goyal, M Ola, R Chawla, ... Materials Today Chemistry 18, 100349 , 2020 2020 Citations: 152
Natural kinase inhibitors for the treatment and management of endometrial/uterine cancer: preclinical to clinical studies RK Singla, S Behzad, J Khan, C Tsagkaris, RK Gautam, R Goyal, ... Frontiers in Pharmacology 13, 801733 , 2022 2022 Citations: 68
COMPARATIVE HIGHLIGHTS ON MERS-COV, SARS-COV-1, SARS-COV-2, AND NEO-COV R Goyal, RK Gautam, H Chopra, AK Dubey, RK Singla, RA Rayan, MA Kamal EXCLI 21, 1245-1272 , 2022 2022 Citations: 52
Insights on fluoroquinolones in cancer therapy: Chemistry and recent developments PC Sharma, R Goyal, A Sharma, D Sharma, N Saini, H Rajak, S Sharma, ... Materials Today Chemistry 17, 100296 , 2020 2020 Citations: 51
Natural products in the management of neurodegenerative diseases R Goyal, P Mittal, RK Gautam, MA Kamal, A Perveen, V Garg, A Alexiou, ... Nutrition & metabolism 21 (1), 26 , 2024 2024 Citations: 50
Natural Products for the Management of Castration-Resistant Prostate Cancer: Special Focus on Nanoparticles Based Studies RK Singla, C Siva, H CHOPRA, S Behzad, H Bansal, R Goyal, ... Frontiers in Cell and Developmental Biology 9, 3020 , 2021 2021 Citations: 47
Natural products derived from medicinal plants and microbes might act as a game-changer in breast cancer: a comprehensive review of preclinical and clinical studies RK Singla, X Wang, S Joon, C Tsagkaris, S Behzad, J Khan, R Gautam, R Goyal ... Critical Reviews in Food Science and Nutrition , 2022 2022 Citations: 46
Therapeutic effect of targeted antioxidant natural products S Mukherjee, H Chopra, R Goyal, S Jin, Z Dong, T Das, T Bhattacharya Discover Nano 19 (1), 144 , 2024 2024 Citations: 43
Insights on prospects of nano-siRNA based approaches in treatment of Cancer R Goyal, H Chopra, I Singh, K Dua, RK Gautam Frontiers in Pharmacology 13, 985670 , 2022 2022 Citations: 39
Green chemistry approaches for thiazole containing compounds as a potential scaffold for cancer therapy D Sharma, V Sharma, A Sharma, R Goyal, RK Tonk, VK Thakur, ... Sustainable Chemistry and Pharmacy 23, 100496 , 2021 2021 Citations: 37
Insights on quercetin therapeutic potential for neurodegenerative diseases and its nano-technological perspectives R Goyal, G Mittal, S Khurana, N Malik, V Kumar, A Soni, H Chopra, ... Current Pharmaceutical Biotechnology 25 (9), 1132-1141 , 2024 2024 Citations: 26
Insights on aspects of apoptosis in neurodegenerative disorders: a comprehensive review R Goyal, K Wilson, A Saharan, RK Gautam, H Chopra, S Gupta, ... Exploration of Medicine 5 (1), 89-100 , 2024 2024 Citations: 24
Chemopreventive potential of dietary nanonutraceuticals for prostate cancer: an extensive review H Chopra, S Bibi, R Goyal, RK Gautam, R Trivedi, TK Upadhyay, ... Frontiers in oncology 12, 925379 , 2022 2022 Citations: 23
Insights on the emerging therapeutic potential of terpenoids as anti-inflammatory agents: a scoping review M Devi, PK Bamrah, R Goyal, M Choudhary, H Chopra Journal of Bio-X Research 7, 0006 , 2024 2024 Citations: 22
Targeting brain tumors with innovative nanocarriers: bridging the gap through the blood-brain barrier K Wadhwa, P Chauhan, S Kumar, R Pahwa, R Verma, R Goyal, G Singh, ... Oncology Research 32 (5), 877 , 2024 2024 Citations: 22
Green chemistry approaches towards the design and synthesis of anti-infective fluoroquinolone derivatives R Goyal, A Sharma, VK Thakur, M Ola, PC Sharma Current Research in Green and Sustainable Chemistry 4, 100044 , 2021 2021 Citations: 17
The role of nanomaterials in enhancing natural product translational potential and modulating endoplasmic reticulum stress in the treatment of ovarian cancer RK Singla, P Sharma, D Kumar, RK Gautam, R Goyal, C Tsagkaris, ... Frontiers in pharmacology 13, 987088 , 2022 2022 Citations: 16
Recent advancements in skin cancer treatment: a critical review R Goyal, S Husain, K Wilson, H Chopra, R Pahwa, M Loganathan, ... Exploration of Medicine 4 (5), 782-812 , 2023 2023 Citations: 15
Pyrazole based furanone hybrids as novel antimalarial: A combined experimental, pharmacological and computational study D Choudhary, I Rani, J Monga, R Goyal, A Husain, P Garg, SL Khokra Central Nervous System Agents in Medicinal ChemistryChemistry-Central … , 2022 2022 Citations: 12
Insights from a brief study of renal calculi: recent diagnostic and treatment approaches A Kumar, R Goyal, K Garg, S Gupta, K Wilson, H Chopra Journal of Bio-X Research 7, 0002 , 2024 2024 Citations: 11